Journal article

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Moritoki Egi, Rinaldo Bellomo, Michael C Reade

CRITICAL CARE | BMC | Published : 2009


Since the first report that intensive insulin therapy reduced mortality in selected surgical critically ill patients, lowering of blood glucose levels has been recommended as a means of improving patient outcomes. In this initial Leuven trial, blood glucose control by protocol using insulin was applied to 98.7% of patients in the intensive group but to only 39.2% (P < 0.0001) of patients in the control group. If appropriately applied, such protocols should decrease both the mean blood glucose concentration and its variability (variation of blood glucose concentration). Thus, it is logically possible that the benefit of intensive insulin therapy in the first Leuven trial was due to a decrease..

View full abstract